VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.
Developer of a medical device designed to offer carbon dioxide angiography. The company's device combines clinical and engineering expertise with human insights to develop carbon dioxide injectors for peripheral interventional angiography for patients with diabetic disease and renal failure, enabling doctors to give proper treatment and benefit from a low rate of complications.
Developler of non-invasive and radiation-free imaging modality technology designed to screen children at risk for kidney reflux to help in early detection. The company's technology is used for kidney reflux, removing the need for complicated procedures and hospital visits, enabling physicians to screen and monitor kidney reflux, and enhancing the patient experience and clinical outcomes.